Cyclic olefin copolymer and curable composition thereof

TW202637685APending Publication Date: 2026-09-16CPC CORPORATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114109370
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-03-13
Publication Date
2026-09-16
Estimated Expiration
2045-03-12

Smart Images

  • Figure TWG2TA001075918_001
    Figure TWG2TA001075918_001
  • Figure TWG2TA001075918_002
    Figure TWG2TA001075918_002
  • Figure TWG2TA001075918_003
    Figure TWG2TA001075918_003
Patent Text Reader

Abstract

A cyclic olefin copolymer has a structure as shown in Formula (I-1) or Formula (I-2):, wherein R 1isor, R 2is hydrogen, halogen or C 1-C 6alkyl, and R 3and R 4are independently selected from the groups consisting of hydrogen, C 1-C 6alkyl, phenyl group and CF 3group. n is a positive integer from
Need to check novelty before this filing date? Find Prior Art

Claims

1. A cyclic olefin copolymer having a structure as shown in formula (I-1) or formula (I-2): Formula (I-1), Formula (I-2), wherein, R1 is OR, R2 is hydroxyl, halogen or C1-C6 alkyl, R3 and R4 are independently selected from the group consisting of hydroxyl, C1-C6 alkyl, phenyl and CF3 groups, n is a positive integer from 5 to 200, and m is a positive integer from 5 to 200.

2. The cyclic olefin copolymer as claimed in claim 1, having a structure as shown in formula (II): Formula (II).

3. The cyclic olefin copolymer as claimed in claim 1, having a structure as shown in formula (III): Formula (III).

4. The cyclic olefin copolymer as described in claim 1, having a structure as shown in formula (IV): Formula (IV).

5. The cyclic olefin copolymer as claimed in claim 1, having a structure as shown in formula (V): Formula (V).

6. A curable composition comprising: a cyclic olefin copolymer as described in any one of claims 1 to 5; and a curing accelerator.

7. The hardenable composition as described in claim 6, wherein, The curing accelerator is selected from the group consisting of imidazole-based curing accelerators, amine-based curing accelerators and organophosphorus-based curing accelerators.

8. The hardenable composition as described in claim 7, wherein, The imidazole-based curing accelerator is selected from the group consisting of imidazole, 2-methylimidazole and 2-methyl-4-ethylimidazole.

9. The hardenable composition as described in claim 7, wherein, The amine-based curing accelerator is 4-dimethylaminopyridine (DMAP).

10. The hardenable composition as described in claim 7, wherein, The organophosphorus curing accelerator is triphenylphosphine.